Return to Trial Database

BTCRC-LUN15-017

A Phase Ib/II Study of Anti-PD-1 Antibody Pembrolizumab and Imprime PGG for Patients with Metastatic Non-small Cell Lung Cancer After Progression on First-Line Chemotherapy

Status

Study Completed

Cancer Type(s)

Study Contact

Trial Locations

All sites in which the trial BTCRC-LUN15-017 being conducted in.

No data was found